IL-17 signaling pathway: IL-17 signaling aggravated the severity of NAFLD in mouse experiments due to the causal contribution of gut microbiota driving IL-17 production in damaged hepatocytes44. Here, IL17A is linked to metabolic dysfunction-associated steatotic liver disease.